• Mashup Score: 0

    The Texas Heart Institute has announced that a research team led by its Vice President for Research Dr. Darren Woodside and Dr. Peter Vanderslice, of the Molecular Cardiology Research Laboratory, has pinpointed a game-changing application for the 7HP349 integrin activator – an immunostimulant developed by Houston-based 7 Hills Pharma, which Woodside and Vanderslice both helped to establish….

    Tweet Tweets with this article
    • Could a simple pill make vaccines work better? Read more about the game-changing study led by our own Dr. Vanderslice and Dr. Woodside in tandem with #UTMB researchers and 7HillsPharma. https://t.co/DBGTRMRM5w #THI #THIResearch #Vaccines